Clinical trial
Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle in Treatment of Premature Ejaculation
NCT06851598 is registered in ClinicalTrials.gov with Abdallah Mohamed Abdallah Mohamed Elgendy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle in Treatment of Premature Ejaculation
- Lead sponsor
- Abdallah Mohamed Abdallah Mohamed Elgendy
- Phase
- Phase 2/3
- Overall status
- Active, not recruiting
- Start date
- July 1, 2024
- Completion date
- March 1, 2025
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.